NBCNBC News·4hHealth
score-0.60
FDA Panel Takes Action on Peptide Treatments, Sparking Broader Safety and Standards Debate
Original
FDA panel recommends controversial treatments
“Word choice 'controversial' appears twice; framing emphasizes disagreement and concern rather than balanced regulatory process.”